Safety and COVID-19 Symptoms in Individuals
Recently Vaccinated with BCG: a Retrospective
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report
Neurological Adverse Events Emerging in Covid-19 Vaccine Trial. Is
Sarcoidosis, a systemic granulomatous disease of unknown etiology, may mimic other conditions at presentation often resulting in delayed diagnosis.These conditions include infections, neoplasms, autoimmune, cardiovascular, and drug-induced diseases. This review highlights the most common sarcoidosis mimics that often lead to pitfalls in diagnosis and delay in appropriate treatment. Prior to invasive testing and initiating immunosuppressants (commonly corticosteroids), it is important to exclude sarcoid mimickers.
Immune checkpoint inhibitors therapies in patients with cancer and
preexisting autoimmune diseases: A meta-analysis of observational studies
SARS-CoV-2, the autoimmune virus
Diverse Functional Autoantibodies in Patients with COVID-19
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
More than a year after COVID-19 emerged, many mysteries persist about the disease: why do some people get so much sicker than others? Why does lung damage sometimes continue to worsen well after the body seems to have cleared the SARS-CoV-2 virus? And what is behind the extended, multi-organ illness that lasts for months in people with ‘long COVID’? A growing number of studies suggest that some of these questions might be explained by the immune system mistakenly turning against the body — a phenomenon known as autoimmunity.
Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis